Corey Chichizola, contributing editor at Cinemablend, discusses Disney's shareholder meeting where CEO Bob Iger told investors that he does not plan on changing Fox Searchlight's business.
We dig into whether this is a smart business move for Disney, whose brand critics say could be disrupted by the specialty studio's edgier, R-rated movies.
Chichizola feels it can only enrich Disney's business since it's currently not making a lot of films that are big awards contenders. CEO Bob Iger noted that he was rooting for Fox Searchlight's "The Shape of Water" and "Three Billboards", since Disney did not have any live action movies nominated for Oscars this year.
We also talk Disney's planned streaming service, and how the platform can differentiate itself from Netflix and Amazon.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
